Cypress Bioscience, Inc. (Nasdaq: CYPB) today announced that its Board of Directors has unanimously concluded that the unsolicited, non-binding proposal ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE